Another clinical study investigated the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of pharmacological ascorbic acid when it is combined with mFOLFOX6 or FOLFIRI with or without bevacizumab regimens in patients with metastatic colorectal cancer or gastric cancer
Maintaining Weight Loss After GLP-1: The Quick Answer Maintaining weight loss after GLP-1 treatment usually requires a structured transition plan: clinician-guided medication decisions, protein-forward meals, fiber-rich foods, resistance training, regular activity, sleep support, weight monitoring, and early check-ins if appetite or weight begins to return
Brand Exenatide is not on the formulary but can be accessed through the NF exceptions pathway: criteria same as above + trial and failure with three preferred products (Ozempic, Rybelsus, Trulicity, Byetta, Bydureon, or Mounjaro)
Weight loss coverage is limited, but cardiovascular risk reduction may be covered
2c, Supplementary Data 6)